Medicinova, Inc. v. Genzyme Corp.

Full title: MEDICINOVA, INC., A DELAWARE CORPORATION, Plaintiff-Appellant v. GENZYME…

Court: United States Court of Appeals for the Federal Circuit

Date published: Dec 14, 2020

2020-1064 (Fed. Cir. Dec. 14, 2020)

Opinion

2020-1064

12-14-2020

MEDICINOVA, INC., A DELAWARE CORPORATION, Plaintiff-Appellant v. GENZYME CORPORATION, A MASSACHUSETTS CORPORATION, Defendant-Appellee

BRUCE G. CHAPMAN, Sheppard, Mullin, Richter & Hampton LLP, Los Angeles, CA, argued for plaintiff-appellant. Also represented by DON PELTO, Washington, DC; MATTHEW G. HALGREN, MARK GERARD RACKERS, San Diego, CA. FRANCIS DIGIOVANNI, Faegre Drinker Biddle & Reath LLP, Wilmington, DE, argued for defendant-appellee. Also represented by MICHAEL CURT LAMBERT, THATCHER A. RAHMEIER; RABIYA KADER, Sanofi, Bridgewater, NJ.

PER CURIAM

NOTE: This disposition is nonprecedential. Appeal from the United States District Court for the Southern District of California in No. 3:14-cv-02513-JLS-KSC, Judge Janis L. Sammartino.

JUDGMENT

BRUCE G. CHAPMAN, Sheppard, Mullin, Richter & Hampton LLP, Los Angeles, CA, argued for plaintiff-appellant. Also represented by DON PELTO, Washington, DC; MATTHEW G. HALGREN, MARK GERARD RACKERS, San Diego, CA. FRANCIS DIGIOVANNI, Faegre Drinker Biddle & Reath LLP, Wilmington, DE, argued for defendant-appellee. Also represented by MICHAEL CURT LAMBERT, THATCHER A. RAHMEIER; RABIYA KADER, Sanofi, Bridgewater, NJ. THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (DYK, BRYSON, and O'MALLEY, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

December 14, 2020

Date

/s/ Peter R. Marksteiner

Peter R. Marksteiner

Clerk of Court